When you buy through our links, we may earn a commission. Our process 'ZDNET Recommends': What exactly does it mean? ZDNET's ...
IgAN, also called Berger’s disease, can cause your kidneys to leak blood (hematuria) and protein (proteinuria) into your pee. Inflammation is part of the immune system’s normal response to injury or ...
Though they have gained significantly more popularity in the last two decades, inflatable tents have been around for ages. Fast to pitch, structurally stable, and easy to transport, these camping ...
LAS VEGAS, NV / ACCESS Newswire / April 8, 2026 / Cytta Corp today announced the merger of IGAN Corp and Cytta Air into a single unified entity, Cytta Air, consolidating all related intellectual ...
Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study 1 40.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years 1 ...
Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study1 40.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1 Fabhalta ...
VOYXACT is the first and only FDA-approved treatment for adults with primary IgAN at risk for disease progression that selectively inhibits A PRoliferation Inducing Ligand (APRIL), a key immune driver ...
BRENTWOOD, N.H., March 12, 2026 (GLOBE NEWSWIRE)-- Enhanced platform now fits nearly 4,000 generator models and delivers independently tested protection up to 110 mph winds, 18 inches of rain per hour ...
Vertex's chief executive, Reshma Kewalramani. Vertex Pharma's bid to expand beyond its cystic fibrosis franchise has taken a big step forward, thanks to positive late-stage clinical data for ...
IgA nephropathy (IgAN), or Berger’s disease, is a kidney condition that occurs when abnormal immunoglobulin A (IgA) antibodies trigger inflammation in the kidneys. Until recently, treatment for IgAN ...
Vera Therapeutics received priority review from the FDA for its biologics license application for atacicept to treat adults with immunoglobulin A nephropathy. The application was submitted under the ...
Patients may self-administer Voyxact after receiving proper training on subcutaneous injection technique. The Food and Drug Administration (FDA) has granted accelerated approval to Voyxact ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results